Skip to content

Checked

A Long-term Observational Study Evaluating Eteplirsen, Golodirsen, or Casimersen in Routine Clinical Practice

NCT06606340 on ClinicalTrials.gov

Study listings come from ClinicalTrials.gov, where sponsors register and update their own studies. A listing does not mean a study is safe or effective, and DatenUS does not recommend any study. Talk with your doctor before joining a clinical trial, and use ClinicalTrials.gov for contact details and full eligibility rules.

Status
Enrolling by invitation
Phase
Observational
Planned enrollment
300
Participants, all sites
U.S. sites
20
In 14 states

Study details

Conditions
Duchenne Muscular Dystrophy
Sponsor
Sarepta Therapeutics, Inc. (Industry)
Sex
Male only
Healthy volunteers
Not accepted
Start
01/07/2019
Primary completion (expected)
12/31/2033
Last updated by sponsor
09/10/2025

Full eligibility rules, contacts and site names: NCT06606340 on ClinicalTrials.gov

Where the study has sites

Cities with at least one listed U.S. site. Some sites may not be enrolling yet.

  • Arkansas: Little Rock
  • California: Los Angeles, Sacramento
  • District of Columbia: Washington D.C.
  • Florida: Gainesville
  • Iowa: Iowa City
  • Maryland: Baltimore
  • Missouri: St Louis
  • New York: New York
  • North Carolina: Durham, Winston-Salem
  • Ohio: Cincinnati, Columbus
  • Pennsylvania: Hershey, Philadelphia, Pittsburgh
  • Texas: Fort Worth, Houston
  • Virginia: Charlottesville
  • Washington: Seattle

Frequently asked questions

What does recruiting mean?
Recruiting means the study is currently enrolling participants. Not yet recruiting means it has been registered but has not started enrolling. Enrolling by invitation means participants are selected by the study team rather than through open enrollment.
How do I join a clinical trial?
Read the full eligibility criteria and contact information on ClinicalTrials.gov, then talk with your doctor about whether a study may be right for you. The study team decides who can enroll.

Source: ClinicalTrials.gov, National Library of Medicine · Last updated 09/10/2025